Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Okazaki

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Chemotherapy|January 1, 1987
Lack of effect of ofloxacin on theophylline pharmacokinetics in ratsO Okazaki, K Miyazaki, H Tachizawa
Biological & Pharmaceutical Bulletin|July 1, 1995
Metabolism of irinotecan to SN-38 in a tissue-isolated tumor modelR Atsumi, O Okazaki, H Hakusui
Biological & Pharmaceutical Bulletin|August 1, 1995
Pharmacokinetics of SN-38 [(+)-(4S)-4,11-diethyl-4,9-dihydroxy-1H- pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4H,12H)-dione], an active metabolite of irinotecan, after a single intravenous dosing of 14C-SN-38 to ratsR Atsumi, O Okazaki, H Hakusui
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1997
Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitorsN Masubuchi, H Hakusui, O Okazaki
Journal of Electrocardiology|February 13, 1999
A simulation study of Torsade de Pointes with M cellsO Okazaki, D Wei, K Harumi
The Japanese Journal of Antibiotics|September 1, 1991
[Intraocular penetration of DR-3355, a new quinolone derivative]M Ooishi, M Miyao, O Okazaki
Chemical Research in Toxicology|March 1, 1993
N-nitroso-N-methylvinylamine: reaction of the epoxide with guanyl and adenyl moieties to yield adducts derived from both parts of the moleculeO Okazaki, M Persmark, F P Guengerich
Chemico-Biological Interactions|September 23, 1998
An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytesN Masubuchi, A P Li, O Okazaki
Scientific Reports|March 20, 2020
Probing dynamical cortical gating of attention with concurrent TMS-EEGYuka O Okazaki, Yuji Mizuno, Keiichi Kitajo
Arzneimittel-Forschung|January 1, 1988
Effects of exogenous ubidecarenone on cardiac action potential and activation time in hypoxic, glucose-free solution. Possible antiarrhythmic action of ubidecarenoneT Tsutsumi, S Sekiya, O Okazaki, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Chemotherapy|January 1, 1987
Lack of effect of ofloxacin on theophylline pharmacokinetics in ratsO Okazaki, K Miyazaki, H Tachizawa
Biological & Pharmaceutical Bulletin|July 1, 1995
Metabolism of irinotecan to SN-38 in a tissue-isolated tumor modelR Atsumi, O Okazaki, H Hakusui
Biological & Pharmaceutical Bulletin|August 1, 1995
Pharmacokinetics of SN-38 [(+)-(4S)-4,11-diethyl-4,9-dihydroxy-1H- pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4H,12H)-dione], an active metabolite of irinotecan, after a single intravenous dosing of 14C-SN-38 to ratsR Atsumi, O Okazaki, H Hakusui
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1997
Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitorsN Masubuchi, H Hakusui, O Okazaki
Journal of Electrocardiology|February 13, 1999
A simulation study of Torsade de Pointes with M cellsO Okazaki, D Wei, K Harumi
The Japanese Journal of Antibiotics|September 1, 1991
[Intraocular penetration of DR-3355, a new quinolone derivative]M Ooishi, M Miyao, O Okazaki
Chemical Research in Toxicology|March 1, 1993
N-nitroso-N-methylvinylamine: reaction of the epoxide with guanyl and adenyl moieties to yield adducts derived from both parts of the moleculeO Okazaki, M Persmark, F P Guengerich
Chemico-Biological Interactions|September 23, 1998
An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytesN Masubuchi, A P Li, O Okazaki
Scientific Reports|March 20, 2020
Probing dynamical cortical gating of attention with concurrent TMS-EEGYuka O Okazaki, Yuji Mizuno, Keiichi Kitajo
Arzneimittel-Forschung|January 1, 1988
Effects of exogenous ubidecarenone on cardiac action potential and activation time in hypoxic, glucose-free solution. Possible antiarrhythmic action of ubidecarenoneT Tsutsumi, S Sekiya, O Okazaki, et al.
Pageof 8